| [1] |
徐建国. 成人术后疼痛治疗进展[J]. 临床麻醉学杂志, 2011, 27(3): 299-301.
|
| [2] |
赵大方, 温超峰, 李燕. 肛肠病术后不同组方阿片类药物镇痛效果观察[J]. 中国肛肠病杂志, 2003, 23(11): 41.
|
| [3] |
Scholl L, Seth P, Kariisa M, et al. Drug and opioid-involved overdose deaths - United States, 2013-2017[J]. Morb Mortal Wkly Rep, 2019, 67(5152): 1419-1427.
|
| [4] |
谢靳希, 邓艳萍, 史录文. 美国阿片类药物滥用危机与中国镇痛药使用与监管[J]. 中国药物滥用防治杂志, 2020, 26(4): 192-197.
|
| [5] |
中国中西医结合学会大肠肛门病专业委员会. 肛门良性疾病围手术期排粪管理中国专家共识[J].中华胃肠外科杂志, 2020, 23(12): 1131-1134.
|
| [6] |
杨继闽, 邱胜民. 氨酚羟考酮片对肛肠病术后镇痛及并发症疗效的研究[J]. 中国新药杂志, 2009, 18(12): 1119-1120+1163.
|
| [7] |
朱钢, 郝玉芬, 林梅. 硫酸吗啡控释片肛肠病术后镇痛149例临床观察[J]. 中国肛肠病杂志, 2003, 23(11): 41.
|
| [8] |
范开明, 李长科. 单剂量吗啡复合纳络酮在肛肠科患者术后镇痛中的应用[J].汕头大学医学院学报, 2011, 24(2): 105-107.
|
| [9] |
李贵鑫, 于滨, 逄承建, 等. 氨酚曲马多片用于治疗肛肠疾病术后镇痛的临床观察[J]. 世界最新医学信息文摘, 2017, 17(34): 19-20.
|
| [10] |
Liu Janet C, Ma Joseph D, Morello Candis M, et al. Naltrexone metabolism and concomitant drug concentrations in chronic pain patients[J]. Journal of Analytical Toxicology, 2014, 38(4): 212-217.
|
| [11] |
Usmani SA, Hollmann J, Goodin A, et al. Effects of hydrocodone rescheduling on opioid use outcomes: A systematic review[J]. J Am Pharm Assoc (2003), 2020, 27: S1544-3191(20)30474-X.
|
| [12] |
Tegon G, Pulzato L, Passarella L, et al. Randomized placebo-controlled trial on local applications of opioids after hemorrhoidectomy[J]. Techniques in Coloproctology, 2009, 13(3): 219-224.
|
| [13] |
杨解人, 宋建国, 黄正明. 药理学[M]. 合肥: 中国科学技术大学出版社, 2012: 128-129.
|
| [14] |
张威, 王荣. 不同种类止痛药对肛肠病术后镇痛的疗效观察[J]. 中国疼痛医学杂志, 2016, 22(5): 398-400.
|
| [15] |
梁建华, 杨余沙, 蒋祖福. 芬太尼透皮贴剂在肛肠病术后镇痛中的应用[J].中国肛肠病杂志, 2009, 29(5): 52-53.
|
| [16] |
崔灿, 秦凯健, 施兵,等. 丁丙诺啡透皮贴对痔术后镇痛效果的临床研究[J/CD]. 中华结直肠疾病电子杂志, 2018, 7(1): 32-35.
|
| [17] |
胡榕, 张传汉. 阿片类药物在慢性非癌性疼痛中的规范化应用[J]. 中国疼痛医学杂志, 2015, 21(2): 133-137.
|
| [18] |
孙涛, 傅志俭, 宋文阁. 阿片类药物在慢性非癌性疼痛中的应用[J]. 中国疼痛医学杂志, 2012, 18(2): 70-72+80.
|
| [19] |
Hero JO, McMurty C, Benson J, et al. Discussing opioid risks with patients to reduce misuse and abuse:evidence from 2 surveys[J]. Ann Fam Med, 2016, 14: 575e577.
|
| [20] |
Hill MV, Stucke RS, McMahon ML, et al. An educational intervention decreases opioid prescribing after general surgical operation[J]. Ann Surg, 2018, 267: 468e472.
|
| [21] |
Livingston-Rosanoff D, Aiken T, Rademacher B, et al. Overprescription of opioids following outpatient anorectal surgery: a single-institution study [J]. Dis Colon Rectum, 2020, 63(11): 1541-1549.
|
| [22] |
Sekhri S, Arora NS, Cottrell H, et al. Probability of opioid prescription refilling after surgery: does initial prescription dose matter?[J]. Ann Surg, 2018, 268(2): 271-276.
|
| [23] |
Hartford LB, Murphy PB, Gray DK, et al. The Standardization of Outpatient Procedure (STOP) Narcotics after anorectal surgery: a prospective non-inferiority study to reduce opioid use[J]. Tech Coloproctol, 2020, 24(6): 563-571.
|
| [24] |
Lu PW, Fields AC, Andriotti T, et al. Opioid prescriptions after hemorrhoidectomy[J]. Dis Colon Rectum, 2020, 63(8): 1118-1126.
|
| [25] |
陆双伟, 朱勇, 周东红, 等.混合痔术后镇痛的研究进展[J]. 结直肠肛门外科, 2014, 20(1): 70-72.
|
| [26] |
Ivatury SJ, Swarup A, Wilson MZ, et al. Prospective evaluation of a standardized opioid reduction protocol after anorectal surgery[J]. J Surg Res, 2020, 256: 564-569.
|
| [27] |
Brummett CM, Waljee JF, Goesling J, et al. New persistent opioid use after minor and major surgical procedures in US adults[J]. JAMA Surg, 2019, 154(3): 272.
|
| [28] |
Hartford LB, Murphy PB, Gray DK, et al. The Standardization of Outpatient Procedure (STOP) Narcotics after anorectal surgery: a prospective non-inferiority study to reduce opioid use[J]. Tech Coloproctol, 2020, 24(6): 563-571.
|
| [29] |
隆清娥, 赵丽, 张程亮. 972例阿片类药物不良反应/事件的回顾性研究[J]. 药物流行病学杂志, 2019, 28(5): 314-318.
|
| [30] |
赵文亭. 阿片类镇痛药物的不良反应[J]. 中国药物经济学, 2015, 10(12): 19-20.
|
| [31] |
Manchikanti L, Manchikanti KN, Pampati V, et al. Prevalence of side effects of prolonged low or moderate dose opioid therapy with concomitant benzodiazepine and/or antidepressant therapy in chronic non-cancer pain[J]. Pain Physician, 2009, 12(1): 259-267.
|
| [32] |
樊文彬, 王熙, 李磊, 等. 肛门病术后便秘发生的原因及临床策略浅析[J]. 结直肠肛门外科, 2020, 26(1): 112-115.
|
| [33] |
刘慧龙.阿片类药物相关不良反应便秘的治疗进展[J].中国新药杂志, 2015, 24(18): 2105-2109.
|
| [34] |
徐美玲, 向光芳, 冯兵, 等. 阿片类药物相关性便秘的治疗药物研究进展[J].华西药学杂志, 2020, 35(4): 458-462.
|
| [35] |
Roeland EJ, Sera CJ, Ma JD. More opioids, more constipation? Evaluation of longitudinal total oral opioid consumption and self-reported constipation in patients with cancer[J]. Support Care Cancer, 2020, 28(4): 1793-1797.
|
| [36] |
徐建国. 疼痛药物治疗学[M]. 北京: 人民卫生出版社, 2007: 96-100.
|
| [37] |
Bruera E, Belzile M, Neumann C, et al. A double-blind, crossover study of controlled release metoclopramide and placebo for the chronic nausea and dyspepsia of advanced cancer[J]. J Pain Symptom Manage, 2000, 19(6): 427-435.
|
| [38] |
冉凤鸣, 臧爱华. 重视阿片类镇痛药物的不良反应[J]. 药品评价, 2012, 9(3): 42-44.
|
| [39] |
Montandon G, Qin W, Liu H, et al. Pre-Bötzinger complex neurokinin-1 receptor-expressing neurons mediate opioid-induced respiratory depression[J]. J Neurosci, 2011, 31: 1292-1301.
|
| [40] |
Qi J, Li H, Zhao TB, et al. Inhibitory effect of endomorphin-2 binding to the mu-opioid receptor in the rat pre-Bötzinger complex on the breathing activity[J]. Mol Neuro biol, 2017, 54: 461-469.
|
| [41] |
朱敏源. 阿片类镇痛药物的不良反应[J]. 智慧健康, 2018, 4(33): 21-22+25.
|
| [42] |
刘聪聪, 刘剑, 于航, 等. 肛肠病术后尿潴留的防治研究进展[J].中国肛肠病杂志, 2020, 40(12): 76-78.
|